We recently compiled a list of the 12 Best Technology Stocks to Invest In for the Long Term. In this article, we are going to ...

Premium IREDA Q3 Results Live Updates: The state-run IREDA is set to announce its financial results for the third quarter of ...

TCS Q3 results 2025 are likely to be muted with a marginal rise in net profit and flat revenue growth on a sequential basis.

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate zanzalintinib showing potential to offset future revenue losses.

I believe quality analysis particularly in the tech sector can be hard to find. I highlight top calls from my firm's Forbes ...

We recently published a list of 10 Best Single Digit Stocks To Buy Now. In this article, we are going to take a look at where ...

We recently published a list of 10 Best Single Digit Stocks To Buy Now. In this article, we are going to take a look at where ...

Dexterra's Q3 2024 results show revenue increase, dividend declaration, stock buyback, and potential for acquisitions. Click ...

State-run renewable energy financier Indian Renewable Energy Development Agency (IREDA) on Thursday (January 9) reported a 26 ...

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis ("UC”) reaches 1,003 of 1,224 ...

Retailer says its third-quarter net income totalled $74.1-million compared with about $43.1-million a year earlier ...

TCS’ order book closed at $10.2 billion in Q3. The management said that the strong order book in Q3 is giving them ...